These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
115 related articles for article (PubMed ID: 434566)
1. Angiotensin-converting enzyme inhibitor (SQ 20881) in the diagnosis of renovascular hypertension. Rosenthal T; Kissin E; Jacob ET; Stern N; Levi Y; Adar R Angiology; 1979 Feb; 30(2):123-8. PubMed ID: 434566 [TBL] [Abstract][Full Text] [Related]
2. Reactive hyperreninemia in renovascular hypertension after angiotensin blockage with saralasin or converting enzyme inhibitor. Case DB; Laragh JH Ann Intern Med; 1979 Aug; 91(2):153-60. PubMed ID: 464461 [TBL] [Abstract][Full Text] [Related]
3. Use of SQ 20881 converting enzyme inhibitor in predicting response to surgery in renovascular hypertension. Rosenthal T; Stern N; Rubinstein Z; Morag B; Adar R Angiology; 1982 Jan; 33(1):11-6. PubMed ID: 6174055 [No Abstract] [Full Text] [Related]
4. Use of the angiotensin I antagonist, SQ 20881, for lateralizing renal venous renin activity. Rosenthal T; Adar R; Stern N; Kisin E; Jacob ET; Rubinstein Z Isr J Med Sci; 1978 Mar; 14(3):388-91. PubMed ID: 640825 [No Abstract] [Full Text] [Related]
5. The effect of the converting enzyme inhibitor SQ 20.881 on kinins, renin-angiotensin-aldosterone and catecholamines in relation to blood pressure in hypertensive patients. Hulthén L; Hökfelt B Acta Med Scand; 1978; 204(6):497-502. PubMed ID: 735881 [TBL] [Abstract][Full Text] [Related]
6. Exaggerated response of renin secretion to captopril (SQ 14225) in renovascular hypertension. Imai Y; Abe K; Otsuka Y; Sakurai Y; Ito T; Sato M; Haruyama T; Omata K; Hiwatari M; Yoshinaga K Jpn Heart J; 1980 Nov; 21(6):793-802. PubMed ID: 7007685 [TBL] [Abstract][Full Text] [Related]
7. [The renin-angiotensin-aldosterone system in the diagnosis of renovascular arterial hypertension]. Sánchez Torres G; Posadas C; Millán AJ; Gutiérrez Fuster E; Serrano Mass P; Rangel J; Cuéllar A Arch Inst Cardiol Mex; 1976; 46(2):198-212. PubMed ID: 938159 [TBL] [Abstract][Full Text] [Related]
8. A discrepancy between the effects of a single oral dose of captopril on blood pressure, plasma renin activity, and serum angiotensin-converting enzyme levels. Lechi A; Covi G; Capuzzo MG; Lechi C; Minuz P; Delva P; Scuro LA Int J Clin Pharmacol Ther Toxicol; 1983 Nov; 21(11):569-74. PubMed ID: 6317579 [TBL] [Abstract][Full Text] [Related]
9. Differences in response to the peptidyldipeptide hydrolase inhibitors SQ 20,881 and SQ 14,225 in normal-renin essential hypertension. Crantz FR; Swartz SL; Hollenberg NK; Moore TJ; Dluhy RG; Williams GH Hypertension; 1980; 2(5):604-9. PubMed ID: 6158478 [TBL] [Abstract][Full Text] [Related]
10. [Usefulness of converting enzyme inhibitors in diagnosis of renovascular hypertension. I. Comparison of the effect of angiotensin converting enzyme inhibition on blood pressure and plasma renin activity in patients with primary hypertension and renovascular hypertension]. Posadzy-Małaczyńska A Przegl Lek; 1997; 54(5):314-9. PubMed ID: 9380805 [TBL] [Abstract][Full Text] [Related]
11. Renin--angiotensin antagonists and the regulation of blood pressure. Samuels AI; Miller ED; Fray JC; Haber E; Barger AC Fed Proc; 1976 Nov; 35(13):2512-20. PubMed ID: 185095 [TBL] [Abstract][Full Text] [Related]
12. Blood kinin system in renal hypertensive patients administered with SQ 20881. Edery H; Rosenthal T; Amitzur G; Stern N Adv Exp Med Biol; 1979; 120B():571-4. PubMed ID: 517251 [TBL] [Abstract][Full Text] [Related]
13. A screening test for renovascular hypertension by means of orally active angiotensin I converting enzyme inhibitor, captopril (SQ 14225). Imai Y; Abe K; Otsuka Y; Sakurai Y; Yoshinaga K Tohoku J Exp Med; 1980 Jul; 131(3):311-2. PubMed ID: 6998048 [TBL] [Abstract][Full Text] [Related]
14. [The captopril test--an aid in the detection of scarring nephropathy as a cause of arterial hypertension in children]. Peco-Antić A; Nastić-Mirić D; Babić D; Kostić M Srp Arh Celok Lek; 1999; 127(9-10):305-11. PubMed ID: 10649899 [TBL] [Abstract][Full Text] [Related]
15. Hormonal and blood pressure changes during converting enzyme inhibition by teprotide. VandenBurg MJ; Sharman VL; Morton JJ; Williams GH; Marsh FP Postgrad Med J; 1981 May; 57(667):283-8. PubMed ID: 6170971 [TBL] [Abstract][Full Text] [Related]
16. Effect of angiotensin converting enzyme inhibition on blood pressure, plasma renin activity and plasma aldosterone in essential hypertension. Gavras H; Gavras I; Textor S; Volicer L; Brunner HR; Rucinska EJ J Clin Endocrinol Metab; 1978 Feb; 46(2):220-6. PubMed ID: 220274 [No Abstract] [Full Text] [Related]
17. Accentuated vascular and endocrine response to SQ 20881 in hypertension. Williams GH; Hollenberg NK N Engl J Med; 1977 Jul; 297(4):184-8. PubMed ID: 195203 [TBL] [Abstract][Full Text] [Related]
19. Hypotensive effects of the renin inhibitor (RI-78) and the converting enzyme inhibitor (teprotide) in conscious monkeys. Takaori K; Hartley LH; Burton J Clin Exp Hypertens A; 1987; 9(2-3):387-90. PubMed ID: 3038400 [TBL] [Abstract][Full Text] [Related]
20. The captopril test in children with renovascular and renal hypertension. Fossali E; Intermite R; Minoja M; Tirelli S; Sereni F Acta Paediatr; 1996 Sep; 85(9):1129-31. PubMed ID: 8888932 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]